Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Ocular Therapeutix CEO and leadership

Zippia score 3.8
Job openings (10)
OverviewJobsSalaryRevenue

Reviews

Demographics

CEO & Executives

Ocular Therapeutix CEO and executives

Executive Summary. Based on our data team's research, Antony Mattessich is the Ocular Therapeutix's CEO. Ocular Therapeutix has 228 employees, of which 27 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Ocular Therapeutix executive team is 44% female and 56% male.
  • 63% of the management team is White.
  • 8% of Ocular Therapeutix management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Ocular Therapeutix?
Share your experience

Rate Ocular Therapeutix's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Antony Mattessich

President and Chief Executive Officer

Antony Mattessich's LinkedIn

Antony Mattessich joined Ocular as Chief Executive Officer in August of 2017. Prior to joining the company, he was Managing Director of Mundipharma International based in Cambridge, England. Previous to his time at Mundipharma, Antony ran the US respiratory, dermatology and pediatrics group at Novartis. He also held several positions at Bristol-Myers Squibb, among them, Managing Director roles in Malaysia/Singapore and The Netherlands, and Head of Operations for the International Medicines Group. Antony holds a BA from the University of California at Berkeley and a Masters in International Affairs from Columbia University.

Amarpreet Sawhney Ph.d

Founder & Executive Chairman

Fred Khosravi

Founder

Charles M. Warden

Board Member

Donald Notman Jr

Chief Financial Officer

Donald Notman Jr's LinkedIn

Donald Notman brings over 20 years of financial operations and senior-level investment banking experience to Ocular Therapeutix. Prior to joining the company, Donald Notman served as Senior Vice President and Chief Financial Officer of Thrasos Therapeutics Inc., where he led the company’s financial operations, business development activities, and strategic planning functions. Previously, Donald Notman served as Managing Director and Head of Private Capital Markets for Leerink Swann LLC (now Leerink Partners), where he was involved in the build-out of the firm’s healthcare investment banking capabilities. Before joining Leerink, Donald Notman held senior level investment banking positions with Deutsche Banc Alex. Brown and Alex. Brown & Sons. Donald Notman received his M.B.A. from The Tuck School of Business at Dartmouth College and his B.A. in Economics from Middlebury College.

Leslie J. Williams

Board Member

Jeffrey S. Heier

Board Member

Seung Suh Hong

Board Member

Christopher G. White

Senior VP

Christopher G. White's LinkedIn

Merilee Raines

Board Member

Do you work at Ocular Therapeutix?

Does leadership effectively guide Ocular Therapeutix toward its goals?

Ocular Therapeutix jobs

Ocular Therapeutix founders

Name & TitleBio
Amarpreet Sawhney Ph.d

Founder & Executive Chairman

Fred Khosravi

Founder

Ocular Therapeutix board members

Name & TitleBio
Antony Mattessich

President and Chief Executive Officer

Antony Mattessich's LinkedIn

Antony Mattessich joined Ocular as Chief Executive Officer in August of 2017. Prior to joining the company, he was Managing Director of Mundipharma International based in Cambridge, England. Previous to his time at Mundipharma, Antony ran the US respiratory, dermatology and pediatrics group at Novartis. He also held several positions at Bristol-Myers Squibb, among them, Managing Director roles in Malaysia/Singapore and The Netherlands, and Head of Operations for the International Medicines Group. Antony holds a BA from the University of California at Berkeley and a Masters in International Affairs from Columbia University.

Charles M. Warden

Board Member

Leslie J. Williams

Board Member

Jeffrey S. Heier

Board Member

Seung Suh Hong

Board Member

Merilee Raines

Board Member

Richard L. Lindstrom

Board Member

Richard L. Lindstrom's LinkedIn

Bruce A. Peacock

Board Member

Alan Crane

Board Member

Tara Butler

Board Member

Ocular Therapeutix leadership demographics

Ocular Therapeutix gender distribution in management team

  • The Ocular Therapeutix executive team is 44% female and 56% male.
  • Ocular Therapeutix is 42% female and 58% male company-wide.
Male
Male
56%
Company-wide: 58%
Female
Female
44%
Company-wide: 42%

Ocular Therapeutix executives by race

Management Team:
  • The most common ethnicity among Ocular Therapeutix executive officers is White.
  • 63% of the management team is White.
  • 15% of Ocular Therapeutix's management is Asian.
  • 10% of the management team is Black or African American.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 67% of employees are White.
  • 17% of employees are Hispanic or Latino.
  • 6% of employees are Black or African American.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Ocular Therapeutix jobs nearby

Ocular Therapeutix executives FAQs

Ocular Therapeutix highest paying jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Ocular Therapeutix, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ocular Therapeutix. The employee data is based on information from people who have self-reported their past or current employments at Ocular Therapeutix. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ocular Therapeutix. The data presented on this page does not represent the view of Ocular Therapeutix and its employees or that of Zippia.

Ocular Therapeutix may also be known as or be related to OCULAR THERAPEUTIX INC, OCULAR THERAPEUTIX, INC, Ocular Therapeutix, Ocular Therapeutix Inc and Ocular Therapeutix, Inc.